Cell-based vaccination against melanoma – background, preliminary results, and perspective

Author： Sun Yuansheng   Paschen Annette   Schadendorf Dirk  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.77, Iss.8, 1999-08, pp. : 593-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current Status of Dendritic Cell-Based Tumor Vaccination

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 544-551

Karger

Access to resources Recommend Favorite

Cell‐based therapies for cardiac disease: a cellular therapist's perspective

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Sesto Fiorentino Study: Background, Methods and Preliminary Results

By  

Psychotherapy and Psychosomatics, Vol. 73, Iss. 4, 2004-06 ,pp. : 216-225

Karger

Access to resources Recommend Favorite

Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1467-1479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 12-16

Karger

Access to resources Recommend Favorite